Irrespective of COVID-19 severity, the plasma levels of TGF-β, especially TGF-β1, were heightened in hospitalized COVID-19 patients, with an abnormal and uncontrolled immune response induced by the SARS-CoV-2 infection [121]. Here, TGFB1 is linked to COVID-19.